Efficacy and Safety of Insulin RinGlar ® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients

Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus Interventions:   Drug: Lantus Solostar, 100 Units/mL Subcutaneous Solution;   Drug: Insulin RinGlar, 100 Units/mL Subcutaneous Solution Sponsor:   Geropharm Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

AbstractPurpose of ReviewChildren and adolescents with acute hyperglycemia and diabetes mellitus frequently have acute, potentially life-threatening presentations which require high-acuity care in an inpatient and often intensive care setting. This review discusses the evaluation and care of hyperglycemia and diabetes mellitus in hospitalized children in both critical and non-critical care settings, highlighting important differences in their care relative to adults.Recent FindingsDiabetic ketoacidosis remains highly prevalent at diagnosis among children with type 1 diabetes, and hyperglycemic hyperosmolar state is increas...
Source: Current Diabetes Reports - Category: Endocrinology Source Type: research
This study addresses principal aspects in the prevention of DFUs. First, the sensor-equipped insole will be evaluated for daily performance in home-based measurements of foot temperatures. Second, a telemedicine structure is tested that evaluates sensor data automatically and proposes suitable intervention measures under the supervision of a physician. Third, predictive models for DFUs will be built using the collected sensor data allowing for interpretations, which in the future may support medical care providers.Trial registrationGerman Clinical Trials Register (DRKS),DRKS00013798. Registered on 18 January 2018.
Source: Trials - Category: Research Source Type: clinical trials
This article describes the concept and design of the trial evaluating the efficacy of this education program called “DiaLife—Living Together with Diabetes”.MethodsThis evaluation study is a cluster randomized controlled trial, in which the study centers will be randomly assigned either to the intervention group or the control group. Study centers will recruit relatives of and patients with DM type 1 and type 2. Members of the intervention group will participate in the education program DiaLife, whereas participants randomized in the control group will act as waiting-list controls. The study will assess th...
Source: Trials - Category: Research Source Type: clinical trials
ConclusionsThe above mention data demonstrated that the hematological profile showed noticeable alterations in children with T1DM and the inflammation and oxidative stress markers were contributed to the hematological abnormalities. The results revealed that some hematological indices can be used in the early detection of T1DM children at risk of diabetic complications.
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Acyl-ghrelin administration increases food intake, body weight, and blood glucose. In contrast, mice lacking ghrelin or ghrelin receptors (GHSRs) exhibit life-threatening hypoglycemia during starvation-like conditions, but do not consistently exhibit overt metabolic phenotypes when given ad libitum food access. These results, and findings of ghrelin resistance in obese states, imply nutritional state dependence of ghrelin’s metabolic actions. Here, we hypothesized that liver-enriched antimicrobial peptide-2 (LEAP2), a recently characterized endogenous GHSR antagonist, blunts ghrelin action during obese states and pos...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
In this study, there were significant differences between diastolic function parameters of the heart. The mitral isovolumic contraction time, contraction time, and isovolumic relaxation time values were different in the patients than in the controls (p
Source: Experimental and Clinical Endocrinology and Diabetes - Category: Endocrinology Authors: Tags: Article Source Type: research
Conclusion. These data demonstrate that DM may contribute to IDD by increasing aggrecan degradation and promoting cell apoptosis, which may represent early indicators of the involvement of DM in the pathogenesis of IDD. Level of Evidence: N/A
Source: Spine - Category: Orthopaedics Tags: BASIC SCIENCE Source Type: research
Conclusion The usability test resulted in positive validation, and the suggestions contributed to improvement of the quality of the functions and interactions, favoring the achievement of the goals of the game. Thus, the technology has properties to improve the care of adolescents with type 1 diabetes mellitus.
Source: Acta Paulista de Enfermagem - Category: Nursing Source Type: research
Conclusion Educational actions on Facebook® are well accepted by young people and can be an important strategy to bring them closer to health services and help them in their self-care actions.
Source: Acta Paulista de Enfermagem - Category: Nursing Source Type: research
Long-acting basal insulins are used for the management of both type 1 and type 2 diabetes mellitus. Long-acting basal insulins were developed utilizing recombinant DNA technology and have been available since 2000 with the approval of insulin glargine U-100 followed by insulin detemir in 2005. In recent years, diabetes management has become more complex with the approval of insulin glargine U-300 and insulin degludec U-100 and U-200. Both insulin glargine U-300 and insulin degludec have been compared with insulin glargine U-100 and have demonstrated longer durations of action, as well as lower rates of hypoglycemia. This r...
Source: Cardiology in Review - Category: Cardiology Tags: New Therapy Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Insulin | Lantus | Research